Techinvention

Enabling One Health through Bio-Innovation

Research & Development

Strategic Advisory & Tech Consulting

In & Out Licensing

Contract Development & Manufacturing

Antimicrobial resistance (AMR) continues to severely affect global health and the global economy. It is one of the most serious public health threats of the 21st century, exacerbated by antibiotic overuse and misuse worldwide.It is responsible for 700,000 deaths annually and is predicted to cause more than 10 million deaths by 2050. It is essential to take the One Health approach to effectively address the AMR issue. The concept of One Health refers to an all-encompassing strategy for improving the well-being of people, animals, and the environment.

To enable and support One Health, TechInvention employs four strategies: research and development, contract development and manufacturing for scale-ups and commercial production, technical and strategic advisory for capacity building, and global access to diagnostics, vaccines, and biopharmaceuticals.

TechInvention at a Glance

Regulatory Status of In-licensed Products

Progress Bars with Headers
Vaccine Candidate
CT Document Submission to NRA
SEC Approval and CT NOC
CT In-progress
CSR Submission to NRA
CSR Approval
Marketing Authorization

*CT – Clinical Trial, NRA – National Regulatory Authority, SEC- Subject Expert Committee, NOC – No Objection Certificate, CSR – Clinical Study Report, OCV- Oral Cholera Vaccine, Tdap – Tetanus, Diphtheria, and Acellular Pertussis , QIV- Quadrivalent Influenza Vaccine 

Global Project & Partners